# Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

> **NCT06843538** · PHASE3 · RECRUITING · sponsor: **TriHealth Inc.** · enrollment: 166 (estimated)

## Conditions studied

- Postoperative Urinary Retention (POUR)

## Interventions

- **DRUG:** Tamsulosin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06843538
- **Lead sponsor:** TriHealth Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-03
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 166 (ESTIMATED)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06843538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06843538, "Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06843538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*